HIV Diagnostic Testing

Similar documents
Immunologic Methods in Diagnosis of HIV Infection. Tehran Medical Sciences Branch, Islamic Azad

HIV Guideline Sakchai Dettrairat

Complicated viral infections

Learning Objectives. New HIV Testing Algorithm from CDC. Overview of HIV infection and disease 3/15/2016

Retroviruses (family Retroviridae) are enveloped, single stranded (+) RNA viruses. members that are oncogenic, are associated

HIV Testing Technology and the Latest Algorithm

2.1 HIV antibody tests

SP.718 Special Topics at Edgerton Center: D-Lab Health: Medical Technologies for the Developing World

HIV Update in Laboratory Testing. Patricia Slev, PhD, D(ABCC)

Trends in molecular diagnostics

Diagnosis of HIV-1 Infection in Children Younger Than 18 Months in the United States

A Summary of Clinical Evidence

Module 3: Overview of HIV Testing Technologies

1 st and 2 nd Generation EIA

Advantages and disadvantages of different types of FDA-approved HIV immunoassays used for screening by generation and platform*

HIV testing has significantly improved

Micropathology Ltd. University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ

The Alphabet Soup of Viral Hepatitis Testing

RNA PCR, Proviral DNA and Emerging Trends in Infant HIV Diagnosis

List the steps in the fourth generation HIV screening algorithm Describe the relationship between rapid HIV antibody tests and the fourth generation

Hiv diagnosis By: k. baesi

Supplementary Online Content

2/10/2015. Experiences and opportunities in the use of dried blood spot specimens in resource limited settings. Presentation

Overview of HIV Testing Practices and Technology

Diagnostic Tests for HIV

HUMAN IMMUNODEFICIENCY VIRUS (HIV) NON-IMMEDIATE NOTIFICATION STD PROGRAM. Version

Identification of Microbes Lecture: 12

Epidemiologists and Laboratory Science

The Challenges in Developing and Commercializing HIV Tests that are Useful in Differentiating VISP/R VISP/R Workshop Bethesda, MD March 2013

Hepatitis C Best Practice Guidelines For Local Health Departments

Diagnostic Methods of HBV and HDV infections

Evolution of HIV Diagnostics. Goals for the 2010 Conference. Bernard M. Branson, M.D. CDC Division of HIV/AIDS Prevention

Adventures in Discordance- HIV Testing

New Generation of Nucleic Acid Testing. Michele Owen, Ph.D Division of HIV/AIDS Prevention Centers for Disease Control & Prevention

Objectives. Seven days of separation. Clinical situation a transplant. The Donor COOMBS MD PHD 1. Laboratory Diagnosis & Monitoring of HIV Infection

Pelagia Research Library. European Journal of Experimental Biology, 2015, 5(10):1-5

HEPATITIS C, ACUTE CRUDE DATA. Number of Cases 5 Annual Incidence a LA County 0.05 California b 0.10 United States b 0.68 Age at Diagnosis Mean 38

2006 HIV Diagnostics Survey

Research Article Decision on conducting HCV Immunoblot and HCV Viral Load Tests Dependent upon the Result of the Screening Tests

HIV Test Technologies, Best Practices, and New Algorithm. Jenny R. McFarlane DSHS HIV Prevention and Care Branch

Diagnosis and Initial Management of HIV/AIDS: What the Primary Care Provider Should Know

SEROLOGICAL DIAGNOSIS OF VIRAL INFECTIONS:

Laboratory Diagnosis of Viral Infections. G. Jamjoom 2005

ACQUIRED IMMUNODEFICIENCY SYNDROME AND ITS OCULAR COMPLICATIONS

Opportunities Created by Diagnostic HCV and HIV Nucleic Acid Tests

Viral Hepatitis Diagnosis and Management

Appendix B: Provincial Case Definitions for Reportable Diseases

Rift Valley Fever Virus: Diagnosis and Vaccines. M. Kariuki Njenga, BVM, PhD Centers for Disease Control and Prevention Nairobi, Kenya

HIV and Public Health: the Basics

MTN 009 Laboratory Logistics

AdvaMedDx Value Assessment Framework in Practice

Women and Viral Load. Together, we can change the course of the HIV epidemic one woman at a time.

HIV and PEP. LTC Rose Ressner WRNMMC ID staff Oct 2014 UNCLASSIFIED

Laboratory diagnosis of congenital infections

TEST REQUEST INFORMATION- VIROLOGY

Diagnosis and Management of Acute HIV

The Latest in HIV Tests: What Do the Results Mean?

EDMA HIV-AIDS TEAM Fact Sheet November 2007

General Terms: Appendix B. National Marrow Donor Program and The Medical College of Wisconsin

Centers for Disease Control and Prevention Zika Diagnosis: Challenges and Opportunities

New HIV Tests and Algorithm: A change we can believe in

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

WHO HIV Drug Resistance Strategy

Susanne Norris Zanto, MPH, MLS (ASCP) CM, SM Montana Public Health Laboratory

List of HIV diagnostics eligible to tender for procurement by WHO in 2011

Hepatitis C Cure The Invisible Epidemic

HEPATITIS B NON-IMMEDIATE NOTIFICATION EPIDEMIOLOGY PROGRAM

Obstetrics and HIV An Update. Jennifer Van Horn MD University of Utah

AIDS in Developing Countries

Chagas disease: Challenges in Diagnostics

In the Name of God. Talat Mokhtari-Azad Director of National Influenza Center

Congenital CMV infection. Infectious and Tropical Pediatric Division Department of Child Health Medical Faculty, University of Sumatera Utara

Guidance for Industry

Schedule of Accreditation

HIV TREATMENT ADHERENCE AND SUPPORT. Leonard Anang Sowah, MBChB, MPH, FACP Asst. Professor of Medicine University of Maryland Medical School

WHO Prequalification of In Vitro Diagnostics PUBLIC REPORT. Product: Alere HIV Combo WHO reference number: PQDx

Viral Genetics. BIT 220 Chapter 16

The ABC s (and D & E s) of the Viral Hepatitides Part 2 DIAGNOSTIC TESTS 3/7/2013

Innovation in Diagnostics. ToRCH. A complete line of kits for an accurate diagnosis INFECTIOUS ID DISEASES

Ability to Identify Acute HIV Infections from Surveillance Data Varies by Diagnostic Testing Algorithm

Learning Objectives: Hepatitis Update. Primary Causes of Chronic Liver Disease in the U.S. Hepatitis Definition. Hepatitis Viruses.

Diagnostic Methods of HBV infection. Zohreh Sharifi,ph.D of Virology Research center, Iranian Blood Transfusion Organization (IBTO)

How do we measure HIV drug resistance. Monique Nijhuis

ARCHITECT HIV Ag/Ab Combo: Moving HIV Diagnostics Forward in the U.S.

Potential Effect of Alternative HIV Testing Algorithms on HIV Case Surveillance

Situation of XMRV and Blood Transfusion. Celso Bianco, MD ISBT Working Party on TTID Lisbon, June 19, 2011

Screening and Diagnosis of Hepatitis Virus Infections

Diagnostic Testing for HIV Type 1 RNA in Seronegative Blood

MP Biomedicals Asia Pacific Pte. Ltd. (formerly Genelabs Diagnostics Pte. Ltd.)

Viral hepatitis. Supervised by: Dr.Gaith. presented by: Shaima a & Anas & Ala a

HIV-1 Genemer Detection Kit Ready to Use Amplification Kit for HIV-1 Specific DNA Fragment Analysis

Application of μmacs Streptavidin MicroBeads for the analysis of HIV-1 directly from patient plasma

2018 HIV and HCV Diagnostic Testing Survey

ANNEX 7. Diagnostics for HIV diagnosis

HIV Testing. ECHO Hep C. Judith Feinberg, MD June 22, 2017

Innovative diagnostics for HIV, HBV and HCV

Frequency of occult hepatitis B in HBsAg seronegative blood donors in a tertiary care hospital in kerala,south India.

Transcription:

In The name of God HIV Diagnostic Testing By : Dr. Shahzamani PhD of Medical virology

Purpose of HIV Testing To identify asymptomatic individuals To diagnose HIV infection in those who practice high risk behavior To prevent secondary transmission Donor screening for blood & tissue products For prophylaxis, Medical management, Treatment t For epidemiological surveillance To diagnose clinically suspected cases

National guidelines for HIV testing National testing policy reiterates the following: - No individual should be made to undergo a mandatory testing for HIV - No mandatory HIV testing should be imposed as a precondition for employment or for providing health care services and facilities - Any HIV testing must be accompanied by a pretest and post test counseling services

Testing strategies t Unlinked & anonymous Surveillance Voluntary & confidential Asymptomatic AIDS cases Research Mandatory Transfusion safety

Testing strategies Surveillance by two tests based on different antigen preparations/ principle Transfusion safety single test. Voluntary three different tests ELISA/Rapid/Simple (E/R/S) based on different antigen preparations /principle

Why? Sequential HIV testing strategy To maximize both sensitivity & specificity for detection of HIV An effective approach for diagnosis even in low prevalence population p High positive predictive value

Lab diagnosis Antibody detection Antigen detection Detection of viral nucleic acid Viral isolation Indirect predictors of HIV infection HIV testing & co nseling sho ld al a s be HIV testing & counseling should always be voluntary & confidential

Laboratory diagnosis of HIV infection Direct demonstration of infective agent - Virus isolation- virus culture - Antigen detection- P24 detection - viral nucleic acid detection- PCR Indirect demonstration of infective agent - Anti -HIV antibody detection

Types of HIV Diagnostic Tests HIV Antibodies HIV 1 RNA HIV p24 Antigen Most Common Test for Established Infection Used for Acute HIV and Indeterminate WB Rarely Used. Future use: 4 th Generation EIA

Specimens to be collected for Blood /Serum/Plasma / Saliva / Urine Antibody detection Note! Specimen requiring storage before shipping to lab: -No longer than 7 days at 4 C - No longer than 3 days at RT - For longer period serum or plasma must be separated from clot or cells and stored at -20 C - For PCR testing samples need to be processed within 48 h 0f collection.

Initial and Supplemental HIV Tests Initial Test - Enzyme Immunoassay (EIA) - Chemiluminescent i Immunoassay (CIA) Supplemental Tests - Western blot - Indirect Immunofluorescence Assay (IFA) - Qualitative HIV-1 RNA

Generation of EIA Tests First Second Third *Fourth *Not US FDA approved as of 10/1/09 Uses crude viral Uses recombinant HIV Detects t IgM and IgG Detects t HIV antibodies lysate antigens or peptides in Sandwich EIA and p24 antigen

HIV - ELISA Interpretation of EIAs Based on color change/fluorescence Change compared with standardized cutoff Result positive or negative No specific antibody reaction information Multiple samples run with traditional EIA

Tests to detect HIV Antibodies Screening tests (ELISA, Rapid, Simple) ELISA (2-3 hours) Rapid tests (minutes) Dot blot assays Particle agglutination HIV Spot tests Simple (½ hour ) Based on ELISA principle

Advantages: Rapid tests 1. Quick 2. Easy to perform 3. No sophisticated t instruments t are required 4. Can be done on single sample Disadvantages: 1. Costly 2. Tedious if large no. samples have to be tested at one time

Rapid Tests Rapid tests can employ a variety of techniques including: Particle agglutination Lateral flow membranes Through flow membranes Comb-dipstick based systems Most have sensitivities and specificities of 99% and 98% respectively

Principle: Flow-through Devices TRIDOT Retroquic &HIVComb Immunocomb

Once established HIV seropositivity is typically y life long Exceptions 1.Late in the course of infection 2.Rapid progressions 3.Early introduction of ART

Confirmatory Tests Western Blot, Line immunoassay WB use antigens from whole virus lysates electrophoretically transferred to a membrane LIA use recombinant or synthetic HIV antigens mechanically applied on to support membrane Presence or absence of bands is scored Highly specific, Labor intensive, expensive -WHO criteria- presence of at least 2 envelope bands (gp120, gp160, gp41)

HIV-1 Western Blot Antigens p = protein gp = glycoprotein Number = molecular weight

Components Used in HIV-1 Western Blot HIV Western blot Strip Color Reagent Y Y Y Enzyme Detector Antihuman IgG Antibodies Y Y Y Y YY Human HIV Antibodies (from patient serum) HIV Antigens (on Western blot)

HIV-1 and HIV-2 Gene Products & Western Blot

Interpretive Criteria for HIV-1 Western Blot Positive Control Negative Indeterminate Positive No bands: One or more bands present Not meeting positive criteria At least two of the Following bands: p24, gp41, gp120/160

Direct Methods of HIV diagnosis: p24 antigen detection EIA for detection of p24 antigen in serum, plasma, CSF or cell culture Can detect infection in window period, in late stage of disease,and in newborns To monitor response to anti-retroviral therapy To monitor disease progression Sensitivity is limited (only 69% in patients with AIDS and low in neonates < 1 month old) Negative test does not rule out HIV infection

Detection of HIV nucleic acid (RNA or DNA) Polymerase chain reaction (PCR) To detect and quantify the viral nucleic acid in infected lymphocytes in blood, in serum and in culture supernatant Application of PCR HIV detection in newborn Window period Resolution of indeterminate ELISA/WB Characterization of isolates Measurement of virus load.

Advantages of PCR over other techniques Capable of detecting proviral DNA Highly sensitive can detect 10 ng of DNA Nucleic acid can be detected in fresh / archival samples Results within few hours Less expensive than virus culture PCR requires less sample material

Viral Load Quantitative measurement of the numbers of HIV- 1 RNA copies in a patient s sample Usually the viral load test is carried out in peripheral blood The test results are expressed HIV RNA copies per milliliter or international unit per milliliter of plasma or body fluids

Virus isolation HIV can be cultured from blood (PBMC), semen, vaginal/cervical specimen, tissue, CSF and plasma Direct stimulation of patient s lymphocytes or co-cultivation of patient s lymphocytes with hhealthy h lymphocytes 98% positivity Virus can be isolated in window period Procedure is expensive, labor intensive and time consuming Procedure is used only in research settings

Virus isolation CO-CULTURE CULTURE METHOD PBMCs from heterologous HIV un-infected donors are stimulated with PHA and after 48 72 hrs the stimulated cells are cultured along with the PBMCs from the patient

HIV Diagnosis during window period Need for laboratory diagnosis in window period - Following untested blood transfusion -Risky heterosexual/homosexual exposure - Needle stick injury By demonstrating virus and virus components -PCR - p24 antigen assay (40%) - Viral culture

Window period Early ELISA & WB- 2.1 months (3wks- 3 mths) Sandwich ELISA (III gen ELISA)- 6wks IV generation ELISA- 16-18 days NAT- 12-14 days

Pediatric HIV Testing Only virological based tests (searching for virus particles) such as: nucleic acid detection Polymerase chain reaction (PCR) RT-PCR Nucleic acid sequence based assays (NASBA) viral culture and p24 antigen testing (dissociation of Ag- Ab complexes) will prove if they are infected or not as maternal antibodies may take up to 18 months to clear

Drug resistance & HIV HIV evolves rapidly within human body has a high replication rate has a high hmutation ti rate Resistant strains can emerge within days if drug pressure is not sufficient to suppress replication. R i i i i d fi i l d if Resistant strains persist indefinitely and can re-emerge if same drugs are stopped and restarted (even if they are not detected by standard resistance assays).

HIVDR is inevitable consequence of ART It is impossible to eliminate or completely prevent drug resistance, it is possible & necessary to minimize drug resistance

In Which Conditions is DR More Likely? Treatment with <3 drugs Inappropriate selection of drugs Adding one drug to a failing regimen Interruption of treatment (even for a few days) Prolonging a failing regimen

Advantages of drug testing Shows which drugs not to use Save costs associated with switching drugs too early or using drugs that are no longer effective Avoid toxicity of inactive drugs May avoid further development of resistance

Types of drug resistance assay Genotypic Testing: Prediction of drug susceptibility based on sequence Phenotypic Testing: Measure of susceptibility to specific drugs Recombinant Assays: RT/PCR portion of patient virus and transfer into a vector PBMC Assay: Culture virus from patient Largely replaced by recombinant assays due to difficulties in reproducibility.

Advantages Genotyping Can be performed rapidly (days) Relatively inexpensive Available in many labs Disadvantages Does not directly measure susceptibility Sometimes difficult to interpret results Not all patterns of resistance mutations are known (esp. for new drugs and combinations) Generally qualitative

Phenotyping Advantages Direct measure of drug susceptibility Quantitative Can immediately test new RT and PR inhibitors Disadvantages Longer time to obtain results (weeks) Relatively complex technology More expensive than genotypic assays Available in fewer labs Clinical cutoff values for drug resistance not clearly defined for all drugs